Poster Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing antitumor T cell immunity
페이지 정보
작성자 DAAN
조회 65회 작성일 24-02-16 16:21
조회 65회 작성일 24-02-16 16:21
본문
| Journal | AACR |
|---|---|
| Name | 표경호, 김동권, 조하니 |
| Year | 2021 |
첨부파일
-
2021-AACR-Poster-AXL.pdf (742.2K)
0회 다운로드 | DATE : 2024-02-16 16:21:20
- 이전글Mechanism study of CJRS-10671 and CJRS-10672 on PDX CD34-NSG mice with investigation of tumor microenvironment and scRNA sequencing 24.02.16
- 다음글Comprehensive preclinical study on GI-101, a novel CD80-IgG4-IL2 variant protein, as a therapeutic antibody candidate with bispecific immuno-oncology target 24.02.16